EGFR and lung cancer: Similar to gefitinib, erlotinib (1 μM) elevated its apoptotic effects to PC-9 lung cancer cells when co-administered with curcumin (25 μM) through the elevation of caspase 3 activities and the downregulation of EGFR proteins.